Invivyd (IVVD) Invested Capital (2020 - 2025)
Invivyd (IVVD) reported Invested Capital of $241.5 million for Q4 2025, up 257.63% on a YoY basis from $67.5 million in Q4 2024, and up 159.53% quarter-over-quarter from $93.1 million in Q3 2025.
Invivyd (IVVD) Invested Capital (2020 - 2025) Analysis & Trends
Invivyd has reported Invested Capital for 6 years, with the latest figure at $241.5 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 257.63% year-over-year to $241.5 million; the trailing twelve-month figure through Dec 2025 stood at $241.5 million (up 257.63% YoY), and the FY2025 full-year result was $241.5 million, up 257.63% from the prior year.
- Invested Capital for Q4 2025 stood at $241.5 million, up from $93.1 million in the prior quarter.
- The five-year high for Invested Capital was $633.2 million in Q3 2021, with the low at -$144.6 million in Q2 2021.
- Historically, Invested Capital has averaged $224.2 million across 5 years, with a median of $210.0 million in 2024.
- Annual changes were most pronounced in 2021 — Invested Capital surged 955.21% — and 2025, when it plunged 69.66%.
- Invivyd's Invested Capital stood at $558.0 million in 2021, then slumped by 36.21% to $356.0 million in 2022, then tumbled by 50.15% to $177.5 million in 2023, then plunged by 61.94% to $67.5 million in 2024, then jumped by 257.63% to $241.5 million in 2025.
- The last three Invested Capital figures came in at $241.5 million (Q4 2025), $93.1 million (Q3 2025), and $42.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 241.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241.54 Mn |
| Sep 30, 2025 | 93.07 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 67.54 Mn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 140.64 Mn |
| Mar 31, 2024 | 178.50 Mn |
| Dec 31, 2023 | 177.47 Mn |
| Sep 30, 2023 | 246.50 Mn |
| Jun 30, 2023 | 281.56 Mn |
| Mar 31, 2023 | 326.75 Mn |
| Dec 31, 2022 | 355.97 Mn |
| Sep 30, 2022 | 377.44 Mn |
| Jun 30, 2022 | 414.84 Mn |
| Mar 31, 2022 | 459.39 Mn |
| Dec 31, 2021 | 558.02 Mn |
| Sep 30, 2021 | 633.21 Mn |
| Jun 30, 2021 | -144.62 Mn |
| Mar 31, 2021 | -103.36 Mn |